Satellos Bioscience Inc. ("Satellos" or the "Company") (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle ...

(“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, ...

(“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the ...

To unlock full rankings, SAT/ACT scores and more, sign up for the U.S. News College Compass!

The study included over 32,000 participants from the UK Biobank dataset. The participants underwent MRI scans of their abdomen to measure the amount of fat around the abdominal organs (visceral ...

While it’s nice to be able to zip up your favorite old pair of jeans again, the most important aspect of your weight is its ...

A new study shows how individual brain cells in the hippocampus respond to pronouns. "This may help us unravel how we remember what we read." ...

Theodore Leng, MD, MS, sat down with David Hutton of Ophthalmology Times to discuss his presentation on Progression of Newly ...

This, according to a new study by Consumer Affairs. The consumer research company analyzed data from all 50 states and ...

Satellos Bioscience has dosed the first subject in a Phase I clinical trial of SAT-3247, a potential treatment for Duchenne ...

Researchers found donations are part of a strategy by the industry to embed itself in universities to influence research and ...

Author Nicholas Lemann discusses his new book on standardized testing and common misconceptions about the history and future ...